Charles Evan Ballantyne - Insider Trading & Ownership

Entity
Individual
Location
27 Hearthstone Road, Hopkinton, MA
Summary
The estimated net worth of Charles Evan Ballantyne is at least $125K dollars as of April 12, 2023. Charles Evan Ballantyne is the Chief Financial Officer of Gain Therapeutics, Inc. and owns shares of Gain Therapeutics, Inc. (GANX) stock worth about $125K.
All Insider Reports
All Insider Reports

Ownership of Charles Evan Ballantyne

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GANX Gain Therapeutics, Inc. Chief Financial Officer $125K Apr 10, 2023

Insider Transactions Reported by Charles Evan Ballantyne:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.